BiotechTube
Home/Cardiol Therapeutics/Dr. Andrew Hamer
DA

Dr. Andrew Hamer

Chief Medical Officer

Cardiol Therapeutics

Therapeutic Areas

Cardiovascular

Cardiol Therapeutics Pipeline

DrugIndicationPhase
CardiolRx™Recurrent PericarditisPhase II

Leadership Team at Cardiol Therapeutics

DE
David Elsley
President, CEO, Director
DC
Dr. Colin Stott
Chief Operating Officer (R&D)
J(
John (Iain) Scott
Chief Financial Officer
DE
Dr. Eldon Smith
Chairman of the Board
View full Cardiol Therapeutics profile